» Articles » PMID: 12468535

Negative Regulation of ERK and Elk by Protein Kinase B Modulates C-Fos Transcription

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Dec 7
PMID 12468535
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we have identified novel regulatory steps involved in the cross-talk between protein kinase B (PKB) and MAPK signaling pathways. We found that PKB down-regulates the Ras-Raf-MEK-ERK pathway by reducing the activity of ERK, which leads to inactivation of the transcription factor Elk1. In addition, PKB is able to reduce protein levels of Elk1. Both events lead to suppression of serum response element (SRE)-dependent transcription and a consequent decrease in the transcription of SRE-containing genes, such as c-fos. Because activation of the Ras/MAPK cascade is reported to increase c-fos transcription before apoptosis, our results are consistent with a specific role for PKB in promoting cell survival. Decrease in c-Fos protein levels in glioblastoma cells with constitutively active PKB provides further support for our observations. Therefore, our findings delineate a novel mechanism regulating immediate-early transcription, which may be involved in the initial steps in PKB-induced oncogenic transformation.

Citing Articles

Angiotensin (1-7) Inhibits Ang II-mediated ERK1/2 Activation by Stimulating MKP-1 Activation in Vascular Smooth Muscle Cells.

Sousa-Lopes A, de Freitas R, Silva Carneiro F, Nunes K, Allahdadi K, Webb R Int J Mol Cell Med. 2020; 9(1):50-61.

PMID: 32832484 PMC: 7422848. DOI: 10.22088/IJMCM.BUMS.9.1.50.


Propofol-induced changes in neurotrophic signaling in the developing nervous system in vivo.

Popic J, Pesic V, Milanovic D, Todorovic S, Kanazir S, Jevtovic-Todorovic V PLoS One. 2012; 7(4):e34396.

PMID: 22496799 PMC: 3319585. DOI: 10.1371/journal.pone.0034396.


Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration.

Lee M, Kim D, Lee J, Lee B, Lee S, Jung H Cancer Sci. 2011; 102(10):1822-8.

PMID: 21722267 PMC: 11158224. DOI: 10.1111/j.1349-7006.2011.02025.x.


Rapid, cell-based toxicity screen of potentially therapeutic post-transcriptional gene silencing agents.

Kolniak T, Sullivan J Exp Eye Res. 2011; 92(5):328-37.

PMID: 21256844 PMC: 3388980. DOI: 10.1016/j.exer.2011.01.004.


The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt.

Somanath P, Vijai J, Kichina J, Byzova T, Kandel E Oncogene. 2009; 28(25):2365-9.

PMID: 19421139 PMC: 2982142. DOI: 10.1038/onc.2009.114.